PPBT
Price
$2.33
Change
-$0.29 (-11.07%)
Updated
Jul 25 closing price
Capitalization
7.01M
VERV
Price
$11.13
Change
+$0.03 (+0.27%)
Updated
Jul 24 closing price
Capitalization
994.04M
11 days until earnings call
Interact to see
Advertisement

PPBT vs VERV

Header iconPPBT vs VERV Comparison
Open Charts PPBT vs VERVBanner chart's image
Purple Biotech
Price$2.33
Change-$0.29 (-11.07%)
Volume$156.89K
Capitalization7.01M
Verve Therapeutics
Price$11.13
Change+$0.03 (+0.27%)
Volume$10.31M
Capitalization994.04M
PPBT vs VERV Comparison Chart in %
Loading...
PPBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PPBT vs. VERV commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PPBT is a StrongBuy and VERV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (PPBT: $2.33 vs. VERV: $11.13)
Brand notoriety: PPBT and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PPBT: 124% vs. VERV: 179%
Market capitalization -- PPBT: $7.01M vs. VERV: $994.04M
PPBT [@Biotechnology] is valued at $7.01M. VERV’s [@Biotechnology] market capitalization is $994.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PPBT’s FA Score shows that 1 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • PPBT’s FA Score: 1 green, 4 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, VERV is a better buy in the long-term than PPBT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PPBT’s TA Score shows that 4 TA indicator(s) are bullish while VERV’s TA Score has 4 bullish TA indicator(s).

  • PPBT’s TA Score: 4 bullish, 6 bearish.
  • VERV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VERV is a better buy in the short-term than PPBT.

Price Growth

PPBT (@Biotechnology) experienced а -10.38% price change this week, while VERV (@Biotechnology) price change was +2.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

PPBT is expected to report earnings on May 21, 2025.

VERV is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($994M) has a higher market cap than PPBT($7.01M). VERV YTD gains are higher at: 97.340 vs. PPBT (-50.320). PPBT has higher annual earnings (EBITDA): -3.71M vs. VERV (-201.62M). VERV has more cash in the bank: 497M vs. PPBT (7.09M). PPBT has less debt than VERV: PPBT (137K) vs VERV (68.6M). VERV has higher revenues than PPBT: VERV (59.6M) vs PPBT (0).
PPBTVERVPPBT / VERV
Capitalization7.01M994M1%
EBITDA-3.71M-201.62M2%
Gain YTD-50.32097.340-52%
P/E Ratio0.00N/A-
Revenue059.6M-
Total Cash7.09M497M1%
Total Debt137K68.6M0%
FUNDAMENTALS RATINGS
PPBT: Fundamental Ratings
PPBT
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
19

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PPBTVERV
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
PPBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BE34.341.28
+3.87%
Bloom Energy Corp
APG35.150.46
+1.33%
APi Group Corporation
LARK26.190.08
+0.31%
Landmark Bancorp
THAR1.49-0.04
-2.35%
Tharimmune Inc.
GMRE6.84-0.19
-2.70%
Global Medical REIT

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with ACXP. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then ACXP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
N/A
ACXP - VERV
52%
Loosely correlated
-8.17%
BEAM - VERV
47%
Loosely correlated
+3.68%
IVEVF - VERV
46%
Loosely correlated
N/A
CRSP - VERV
45%
Loosely correlated
-1.97%
AXON - VERV
44%
Loosely correlated
+3.63%
More